116 related articles for article (PubMed ID: 1381610)
21. Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay.
Thibert V; Bellucci S; Edelman L; Tandon NN; Legrand C
Thromb Haemost; 1992 Nov; 68(5):600-5. PubMed ID: 1280864
[TBL] [Abstract][Full Text] [Related]
22. The effect of platelet membrane antibodies on aggregation and release.
Kaplan KL; Nachman RL
Br J Haematol; 1974 Dec; 28(4):551-60. PubMed ID: 4477019
[No Abstract] [Full Text] [Related]
23. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency.
Arai M; Yamamoto N; Moroi M; Akamatsu N; Fukutake K; Tanoue K
Br J Haematol; 1995 Jan; 89(1):124-30. PubMed ID: 7530476
[TBL] [Abstract][Full Text] [Related]
24. Platelet membrane glycoprotein IV (CD36) is involved in arachidonic acid induced-platelet aggregation.
Dutta-Roy AK; Crosbie LC; Gordon MJ; Campbell FM
Biochem Soc Trans; 1996 May; 24(2):167S. PubMed ID: 8736825
[No Abstract] [Full Text] [Related]
25. Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.
Carroll RC; Worthington RE; Boucheix C
Biochem J; 1990 Mar; 266(2):527-35. PubMed ID: 2317202
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against platelet membrane glycoproteins. II. Influence on ADP- and collagen-induced platelet aggregation, crossed immunoelectrophoresis studies and relevance to Glanzmann's thrombasthenia.
Jenkins CS; Ali-Briggs EF; Clemetson KJ
Br J Haematol; 1981 Nov; 49(3):439-47. PubMed ID: 6457625
[TBL] [Abstract][Full Text] [Related]
27. A novel polymorphism in glycoprotein IV (replacement of proline-90 by serine) predominates in subjects with platelet GPIV deficiency.
Kashiwagi H; Honda S; Tomiyama Y; Mizutani H; Take H; Honda Y; Kosugi S; Kanayama Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1993 May; 69(5):481-4. PubMed ID: 7686693
[TBL] [Abstract][Full Text] [Related]
28. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction.
Leung LL; Li WX; McGregor JL; Albrecht G; Howard RJ
J Biol Chem; 1992 Sep; 267(25):18244-50. PubMed ID: 1381367
[TBL] [Abstract][Full Text] [Related]
29. Platelet-collagen interaction. Inhibition by a monoclonal antibody raised against collagen receptor.
Chiang TM; Jin A; Kang AH
J Immunol; 1987 Aug; 139(3):887-92. PubMed ID: 3598192
[TBL] [Abstract][Full Text] [Related]
30. Adhesive functions of platelets lacking glycoprotein IV (CD36).
Tandon NN; Ockenhouse CF; Greco NJ; Jamieson GA
Blood; 1991 Dec; 78(11):2809-13. PubMed ID: 1720035
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the thrombin-platelet reactions by DuP 714.
Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
[TBL] [Abstract][Full Text] [Related]
32. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
33. Effects of atorvastatin on ADP-, arachidonic acid-, collagen-, and epinephrine-induced platelet aggregation.
Zhao L; Liu D; Liu B; Hu H; Cui W
J Int Med Res; 2017 Feb; 45(1):82-88. PubMed ID: 27913744
[TBL] [Abstract][Full Text] [Related]
34. Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets.
Tandon NN; Holland EA; Kralisz U; Kleinman HK; Robey FA; Jamieson GA
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):535-42. PubMed ID: 1826081
[TBL] [Abstract][Full Text] [Related]
35. [Effect of heparin on platelet aggregation in vitro].
Róka L; Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
[TBL] [Abstract][Full Text] [Related]
36. Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians.
Curtis BR; Aster RH
Transfusion; 1996 Apr; 36(4):331-4. PubMed ID: 8623134
[TBL] [Abstract][Full Text] [Related]
37. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms complexes with platelet membrane glycoprotein IV (CD36).
Siddiqui FA; Lian EC
Biochem Int; 1992 Jul; 27(3):485-96. PubMed ID: 1384492
[TBL] [Abstract][Full Text] [Related]
38. Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.
Molica F; Morel S; Meens MJ; Denis JF; Bradfield PF; Penuela S; Zufferey A; Monyer H; Imhof BA; Chanson M; Laird DW; Fontana P; Kwak BR
Thromb Haemost; 2015 Aug; 114(2):325-36. PubMed ID: 25947940
[TBL] [Abstract][Full Text] [Related]
39. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of human platelet aggregation by eosinophils.
Maziero AM; Lorenzetti R; Donato JL; Lilla S; De Nucci G
Life Sci; 2013 Sep; 93(9-11):416-22. PubMed ID: 23871985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
